Kindred Biosciences, Inc. (KIN) Financials

NASDAQ Currency in USD Disclaimer

$9.25

north_east NA Past Year
Day's range
$9.24
Day's range
$9.26
$60M$60M$40M$40M$20M$20M$0$0-$20M-$20M-$40M-$40M-$60M-$60M-$80M-$80MEarning201420142015201520162016201720172018201820192019202020200%0%-500%-500%-1000%-1000%-1500%-1500%-2000%-2000%-2500%-2500%-3000%-3000%-3500%-3500%Profit Margin
Profit Margin
Revenue
Earnings

KIN Income statement / Annual

Last year (2020), Kindred Biosciences, Inc.'s total revenue was $42.16 M, an increase of 890.70% from the previous year. In 2020, Kindred Biosciences, Inc.'s net income was -$23.62 M. See Kindred Biosciences, Inc.,s key income statements, including revenue, expenses, profit, and income.

Period FY-2020 FY-2019 FY-2018 FY-2017 FY-2016 FY-2015 FY-2014 FY-2013 FY-2012
Period Ended 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016 12/31/2015 12/31/2014 12/31/2013 12/31/2012
Operating Revenue $42.16 M $4.26 M $1.97 M $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Cost of Revenue $4.63 M $587,000.00 $324,000.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Gross Profit $37.54 M $3.67 M $1.64 M $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Gross Profit Ratio 0.89 0.86 0.84 0 0 0 0 0 0
Research and Development Expenses $31.28 M $28.31 M $26.40 M $17.67 M $13.86 M $19.41 M $18.69 M $3.14 M $75,000.00
General & Administrative Expenses $21.98 M $37.93 M $22.08 M $11.90 M $6.84 M $6.86 M $8.54 M $1.08 M $45,000.00
Selling & Marketing Expenses $0.00 $0.00 $4.42 M $2.08 M $1.47 M $992,000.00 $0.00 $0.00 $0.00
Selling, General & Administrative Expenses $21.98 M $37.93 M $26.50 M $13.99 M $8.31 M $7.85 M $8.54 M $1.08 M $45,000.00
Other Expenses $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Operating Expenses $53.26 M $66.24 M $52.90 M $31.65 M $22.17 M $27.26 M $27.23 M $4.22 M $120,000.00
Cost And Expenses $57.89 M $66.82 M $53.22 M $31.65 M $22.17 M $27.26 M $27.23 M $4.22 M $120,000.00
Interest Income $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Interest Expense $1.83 M $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $56.00 $0.00
Depreciation & Amortization $4.68 M $2.54 M $805,000.00 $475,000.00 $155,000.00 $146,000.00 $58,000.00 $3,129.00 $0.00
EBITDA -$15.29 M -$58.85 M -$48.89 M -$30.40 M -$22.34 M -$26.98 M -$27.08 M -$4.21 M -$120,000.00
EBITDA Ratio -0.36 -13.83 -24.87 0 0 0 0 0 0
Operating Income Ratio -0.47 -14.42 -25.27 0 0 0 0 0 0
Total Other Income/Expenses Net -$1.83 M $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 -$56.00 $0.00
Income Before Tax -$21.80 M -$61.39 M -$49.69 M -$30.88 M -$22.50 M -$27.13 M -$27.14 M -$4.21 M -$120,000.00
Income Before Tax Ratio -0.52 -14.42 -25.27 0 0 0 0 0 0
Income Tax Expense $1.83 M $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $56.00 $0.00
Net Income -$23.62 M -$61.39 M -$49.69 M -$30.88 M -$22.50 M -$27.13 M -$27.14 M -$4.21 M -$120,000.00
Net Income Ratio -0.56 -14.42 -25.27 0 0 0 0 0 0
EPS -0.6 -1.59 -1.6 -1.23 -1.13 -1.37 -1.44 -1.13 -0.0255
EPS Diluted -0.6 -1.59 -1.6 -1.23 -1.13 -1.37 -1.44 -1.13 -0.0255
Weighted Average Shares Out $39.29 M $38.66 M $31.00 M $25.08 M $19.87 M $19.77 M $18.78 M $3.73 M $4.71 M
Weighted Average Shares Out Diluted $39.29 M $38.66 M $31.00 M $25.08 M $19.87 M $19.77 M $18.78 M $3.73 M $4.71 M
Link